Accurate, noninvasive continuous monitoring of cardiac output by whole-body electrical bioimpedance

Chest

Volumn 125, Issue 4, 2004, Pages 1431-1440

  Cotter, Gad ^a   Moshkovitz, Yaron ^b   Kaluski, Edo ^a   Cohen, Amram J ^e   Miller, Hilton ^c,d   Goor, Daniel ^b   Vered, Zvi ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e NONE

Author keywords

Cardiac function test; Cardiac output; Congestive heart failure

Indexed keywords

VASODILATOR AGENT;

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; HEART CATHETERIZATION; HEART OUTPUT; HUMAN; IMPEDANCE CARDIOGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VALIDATION PROCESS;

EID: 2442673375     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.4.1431     Document Type: Article

References (35)

1. Cotter G, Williams SG, Vered Z, et al. The role of cardiac power in heart failure. Curr Opin Cardiol 2003; 18:215-222
2. Cotter G, Fincke R, Lowe A, et al. Hemodynamic parameters in cardiogenic shock due to myocardial infarction: a report from the SHOCK trial registry [abstract]. Circulation 2003; 108:539
3. Cotter G, Moshkovitz Y, Milovanov O, et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail 2002; 4:227-234
4. Cotter G, Moshkovitz Y, Kaluski E, et al. The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 2003; 5:443-451
5. Marmor A, Schneeweiss A. Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol 1997; 29:422-428
6. Williams SG, Cooke GA, Wright DJ, et al. Peak exercise cardiac power output: a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001; 22:1496-1503
7. Cohen-Solal A, Tabet JY, Logeart D, et al. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J 2002; 23:806-814
8. Mohr R, Rath S, Meir O, et al. Changes in systemic vascular resistance detected by the arterial resistometer: preliminary report of a new method tested during percutaneous transluminal coronary angioplasty. Circulation 1986; 74:780-785
9. Torre-Amione G, Young JB, Colucci ES, et al. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 2003; 42:140-147
10. Teerlink JR, Massie BM, Cleland JG, et al, for the Ritz 1 Investigators. A double-blind, parallel-group, multi-center, placebo-controlled study to investigate the efficacy and safety of tezosentan in reducing symptoms in patients with acute decompensated heart failure (RITZ 1) [abstract]. Circulation 2001; 104:II-526
11. VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized trial. JAMA 2002; 287:1531-1540
12. Cotter G, Faibel H, Barash P, et al. High-dose nitrates in the immediate management of unstable angina: optimal dosage, route of administration, and therapeutic goals. Am J Emerg Med 1998; 16:219-224
13. Kaluski E, Kobrin I, Zimlichman R, et al. RITZ-5: randomized intravenous tezosentan (an endothelin ET-A/B antagonist) for the treatment of pulmonary edema: a prospective randomized, multicenter, double-blind placebo controlled study. J Am Coll Cardiol 2003; 41:204-210
14. Cohen AJ, Arnaudov D, Zabeeda D, et al. Non-invasive measurement of cardiac output during coronary artery bypass grafting. Eur J Cardiothorac Surg 1998; 14:64-69
15. Baker LE. Principles of impedance technique. IEEE Eng Med Biol 1989; 3:11-15
16. Djordjevich L, Sadove MS. Basic principles of electrohaemodynamics. J Biomed Eng 1981; 3:25-33
17. Kedrov AA. An attempt of the quantify assessment of the central and peripheral circulation by electrometrical method. Klin Med 1948; 26:32-51
18. Kubicek WG, Karnegis JN, Patterson RP, et al. Development and evaluation of an impedance cardiac output system. Aerosp Med 1966; 37:1208-1212
19. Kubicek WG, Kottke FJ, Ramos MU, et al. The Minnesota impedance cardiograph: theory and applications. Biomed Eng 1974; 9:410-416
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310
21. Robin ED, McCauley RF. Monitor wizards can be dangerous. Chest 1998; 114:1151-1153
22. Dalen JE, Bone RC. Is it time to pull the pulmonary artery catheter? JAMA 1996; 276:916-918
23. Connors AF, Speroff T, Dawson NV, et al, for the SUPPORT investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996; 276:889-897
24. Raaijmakers E, Faes ThJC, Scholten RJPM, et al. A meta-analysis of published studies concerning the validity of thoracic impedance cardiography. Ann NY Acad Sci 1999; 873:121-134
25. Patterson RP, Witsoe DA, From A. Impedance stroke volume compared with dye and electromagnetic flowmeter values during drug-induced inotropic and vascular changes in dogs. Ann N Y Acad Sci 1999; 873:143-148
26. Marik PE, Pendelton JE, Smith R. A comparison of hemodynamic parameters derived from transthoracic electrical bioimpedance with those parameters obtained by thermodilution and ventricular angiography. Grit Care Med 1997; 25:1545-1550
27. Tischenko MI. Estimation of stroke volume by integral rheogram of the human body [in Russian]. Sechenov Phisiological J 1973; 59:1216-1224
28. Koobi T, Kaukinen S, Turjanmaa VM, et al. Whole-body impedance cardiography in the measurement of cardiac output. Grit Care Med 1997; 25:779-785
29. Lamberts R, Visser KR, Zijlstra WG. Impedance cardiography. Assen, The Netherlands: Van Gorkum, 1984; 21-94
30. Imhoff M, Lehner JH, Lohelin D. Noninvasive whole-body electrical bioimpedance cardiac output and invasive thermodilution cardiac output in high-risk surgical patients. Crit Care Med 2000; 28:2812-2818
31. Davidson CJ, Fishman RF, Bonow RD. Cardiac catheterization. In: Branwald E, ed. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia, PA: W.B. Saunders Company, 1997; 192
32. van Grondelle A, Ditchey RV, Groves BM, et al. Thermodilution method overestimates low cardiac output in humans. Am J Physiol 1983; 245:690-692
33. Kohanna FH, Cunningham JN. Monitoring of cardiac output by thermodilution after open-heart surgery. J Thorac Cardiovasc Surg 1977; 73:451-457
34. 2-rebreathing and direct Fick method. Acta Anaesthesiol Scand 1995; 39:245-251
35. Nanas JN, Anastasiou-Nana MI, Sutton RB, et al. Comparison of Fick and dye cardiac outputs during rest and exercise in 1,022 patients. Can J Cardiol 1986; 2:195-199